This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Sign In
Don’t have an account?
  • Products
  • Therapy Areas
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Bayer cross
BAYER FOR PROFESSIONALSYour Resource Portal
  • Ophthalmology
  • EYLEA® (aflibercept) 8 mg
  • EYLEA® (aflibercept) 2 mg
  • Oncology
  • Nubeqa® (darolutamide)
  • Xofigo®▼ (radium-223 dichloride)
  • Cardiology
  • Beyonttra®▼ (acoramidis)
  • Kerendia®▼ (finerenone)
  • Xarelto® (rivaroxaban)
  • Women's Health
  • Angeliq® (1mg estradiol hemihydrate and 2mg drospirenone)
  • Jaydess®▼ (13.5mg levonorgestrel)
  • Kyleena® (19.5mg levonorgestrel)
  • Mirena® (52mg levonorgestrel)
  • Qlaira® (estradiol valerate/dienogest)
  • Service Optimisation & Formularies
  • Risk Minimisation Materials
  • Ophthalmology
  • Oncology
  • Cardiology
  • Women's Health
  • Ophthalmology Resources
  • Oncology Resources
  • Cardiology Resources
  • Women's Health Resources
  • Ophthalmology Events & On Demand Webinars
  • Oncology Events & On Demand Webinars
  • Cardiology Events & On Demand Webinars
  • Women's Health Events & On Demand Webinars
  • Ophthalmology Learning Zone
  • Oncology Learning Zone
  • Cardiology Learning Zone
  • Women's Health Learning Zone
  • Ophthalmology Podcasts
  • Oncology Podcasts
  • Cardiology Podcasts
  • Women's Health Podcasts
closesearch
Recent Searches
    • Products
    • Therapy Areas
    • Resources
    • Events & Webinars
    • Learning Zone
    • Podcasts
    • Ophthalmology
    • EYLEA® (aflibercept) 8 mg
    • EYLEA® (aflibercept) 2 mg
    • Oncology
    • Nubeqa® (darolutamide)
    • Xofigo®▼ (radium-223 dichloride)
    • Cardiology
    • Beyonttra®▼ (acoramidis)
    • Kerendia®▼ (finerenone)
    • Xarelto® (rivaroxaban)
    • Women's Health
    • Angeliq® (1mg estradiol hemihydrate and 2mg drospirenone)
    • Jaydess®▼ (13.5mg levonorgestrel)
    • Kyleena® (19.5mg levonorgestrel)
    • Mirena® (52mg levonorgestrel)
    • Qlaira® (estradiol valerate/dienogest)
    • Service Optimisation & Formularies
    • Risk Minimisation Materials
    • Ophthalmology
    • Oncology
    • Cardiology
    • Women's Health
    • Ophthalmology Resources
    • Oncology Resources
    • Cardiology Resources
    • Women's Health Resources
    • Ophthalmology Events & On Demand Webinars
    • Oncology Events & On Demand Webinars
    • Cardiology Events & On Demand Webinars
    • Women's Health Events & On Demand Webinars
    • Ophthalmology Learning Zone
    • Oncology Learning Zone
    • Cardiology Learning Zone
    • Women's Health Learning Zone
    • Ophthalmology Podcasts
    • Oncology Podcasts
    • Cardiology Podcasts
    • Women's Health Podcasts
    You are now leaving BayerPro

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    Resource Banner Image

    Nephrology & Cardiology Products

    Beyonttra®▼ (acoramidis) - Overview
    About Beyonttra
    Beyonttra (acoramidis) Prescribing Information
    PP-BEY-GB-0213, March 2026
    Risk Minimisation Materials
    Visit to access Risk Minimisation Materials for Xarelto
    Xarelto® (rivaroxaban) Prescribing Information
    PP-XAR-GB-3676, March 2026
    Kerendia®▼ (finerenone)
    Product Page
    Kerendia (finerenone) UK Prescribing Information
    PP-KER-GB-0903, March 2026

    Oncology Products

    NUBEQA® (darolutamide)
    About NUBEQA
    NUBEQA Prescribing Information
    PP-NUB-GB-2950, March 2026
    Xofigo®▼ (radium-223 dichloride)
    In mCRPC
    Xofigo Prescribing Information
    PP-XOF-GB-0743, March 2026

    Women's Health Products

    View more
    Qlaira® (Estradiol valerate/dienogest)
    Qlaira Prescribing information
    PP-PF-WHC-IUS-GB-0115, March 2026
    Mirena® (52mg levonorgestrel)
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0114, March 2026
    Kyleena® 19.5mg levonorgestrel
    Kyleena® Prescribing Information
    PP-PF-WHC-IUS-GB-0117, March 2026
    Angeliq® (1mg estradiol hemihydrate and 2mg drospirenone)
    Introduction to Angeliq
    Angeliq Prescribing Information
    PP-ANG-GB-0012, March 2026

    Ophthalmology

    EYLEA® (aflibercept) 2 mg
    Discover data and resources about EYLEA 2 mg
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-2793, March 2025
    EYLEA® (aflibercept) 8 mg
    Discover data and resources about EYLEA 8 mg
    EYLEA® (aflibercept) Prescribing Information
    PP-EYL-GB-3129, March 2026